STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy
Nima Parvaneh, Rasol Molatefi, Conor Gruber, Sajjad Biglari, Leila Moradi, Yoann Seeleuthner, Fatima Ailal, Ahmed Aziz Bousfiha, Neda Pak, Camille Soudée, Jean-Laurent Casanova, Jérémie Rosain, Dusan Bogunovic, Mohammad Reza Fazlollahi, Mohammad Shahrooei, Jacinta Bustamante · 2026
Read STAT2 R148 variant: A 16th-century founder mutation and clinical response to high-dose JAK inhibitor therapy by Nima Parvaneh, Rasol Molatefi, Conor Gruber, Sajjad Biglari, Leila Moradi, Yoann Seeleuthner, Fatima Ailal, Ahmed Aziz Bousfiha, Neda Pak, Camille Soudée, Jean-Laurent Casanova, Jérémie Rosain, Dusan Bogunovic, Mohammad Reza Fazlollahi, Mohammad Shahrooei, Jacinta Bustamante (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13215009.txt.
Description
Nima Parvaneh leads a large team reporting in 2026 two Iranian patients with a rare inherited variant that leaves an antiviral signal permanently switched on. The variant, traced to a sixteenth-century founder, causes life-threatening brain inflammation and lung failure, and many patients die young.
Both patients carried two copies of the same STAT2 gene change, which blocks the off-switch for interferon signalling. Early genetic recognition matters, the authors stress, because high-dose JAK inhibitor drugs can damp the runaway pathway. Their cases add clinical detail on presentation and treatment response. The report argues this devastating condition belongs on the treatable list when spotted fast enough.
Catalog record
| CREATOR | Nima Parvaneh, Rasol Molatefi, Conor Gruber, Sajjad Biglari, Leila Moradi, Yoann Seeleuthner, Fatima Ailal, Ahmed Aziz Bousfiha, Neda Pak, Camille Soudée, Jean-Laurent Casanova, Jérémie Rosain, Dusan Bogunovic, Mohammad Reza Fazlollahi, Mohammad Shahrooei, Jacinta Bustamante |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |